Loading insider details...
Beta
Latest Form 4 (Mar 17, 2026): Grant/Award of 4,266,211 TLPH shares, $2.50M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 17, 2026 | TALPHERA, INC. (TLPH) | Grant/Award | 4,266,211 | $2.50M |
| Dec 19, 2025 | Evoke Pharma Inc (EVOK) | Other (see footnotes) | 148,153 | $1.63M |
| Jun 9, 2025 | AYTU BIOPHARMA, INC (AYTU) | Purchase | 4,000,000 | $6.00M |
| Apr 2, 2025 | TALPHERA, INC. (TLPH) | Grant/Award | 4,266,211 | $2.50M |
| Jan 30, 2025 | Evoke Pharma Inc (EVOK) | Sale | 41 | $179.87 |
| Jun 18, 2024 | AYTU BIOPHARMA, INC (AYTU) | In-the-Money Exercise | 815,217 | n/a |
| Mar 21, 2024 | TALPHERA, INC. (TLPH) | Other (see footnotes) | 324,675 | n/a |
| Mar 15, 2024 | TALPHERA, INC. (TLPH) | In-the-Money Exercise | 755,000 | $3.77M |
| Jan 24, 2024 | TALPHERA, INC. (TLPH) | Disposition to Issuer | 2,205,883 | n/a |